Back to Search
Start Over
Supplementary Figure 1 from Phase I Safety, Pharmacokinetic, and Pharmacodynamic Study of SAR245409 (XL765), a Novel, Orally Administered PI3K/mTOR Inhibitor in Patients with Advanced Solid Tumors
- Publication Year :
- 2023
- Publisher :
- American Association for Cancer Research (AACR), 2023.
-
Abstract
- PDF file - 1005KB, Supplementary Figure 1. Mean (+ or - SE) SAR245409 Plasma Concentration-Time Profiles on Days 1 and 27 of Cycle 1.
Details
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....479be25cd34a2fdd20af7814a8ec740d
- Full Text :
- https://doi.org/10.1158/1078-0432.22448604.v1